Johns Hopkins scientists report having used a commercially available drug to successfully “rescue” animal brain cells that they had intentionally damaged by manipulating a newly discovered gene that links susceptibility genes for schizophrenia and autism.

Breast cancer therapy that’s customized for each patient’s personal genetic makeup is one step closer to reality, thanks to a new use for crime-lab technology pioneered at Roswell Park Cancer Institute (RPCI). A team led by Petr Starostik, MD, chief of RPCI’s Clinical Molecular Diagnostics lab, is using CSI-type methods to multiply the reliability of [...]